BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 22901370)

  • 1. Post-stroke depression: an update.
    Espárrago Llorca G; Castilla-Guerra L; Fernández Moreno MC; Ruiz Doblado S; Jiménez Hernández MD
    Neurologia; 2015; 30(1):23-31. PubMed ID: 22901370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance.
    Mortensen JK; Andersen G
    Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in antidepressants for treating post-stroke depression.
    Paolucci S
    Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-stroke depression: recognition and treatment interventions].
    Arseniou S; Arvaniti A; Samakouri M
    Psychiatriki; 2011; 22(3):240-8. PubMed ID: 21971199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-stroke depression: mechanisms, translation and therapy.
    Loubinoux I; Kronenberg G; Endres M; Schumann-Bard P; Freret T; Filipkowski RK; Kaczmarek L; Popa-Wagner A
    J Cell Mol Med; 2012 Sep; 16(9):1961-9. PubMed ID: 22348642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-stroke depression: Mechanisms and pharmacological treatment.
    Villa RF; Ferrari F; Moretti A
    Pharmacol Ther; 2018 Apr; 184():131-144. PubMed ID: 29128343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does prestroke depression impact poststroke depression and treatment?
    Ried LD; Jia H; Cameon R; Feng H; Wang X; Tueth M
    Am J Geriatr Psychiatry; 2010 Jul; 18(7):624-33. PubMed ID: 20220578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance and possibilities of therapy of post-stroke depression].
    Trusova NA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression.
    Bhogal SK; Teasell R; Foley N; Speechley M
    J Am Geriatr Soc; 2005 Jun; 53(6):1051-7. PubMed ID: 15935033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poststroke Depression: An Update.
    Robinson RG; Jorge RE; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 2024; 36(1):22-35. PubMed ID: 37559511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychopharmacology of brain vascular disease/poststroke depression.
    Jones M; Corcoran A; Jorge RE
    Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview.
    Gao Z; Wang Y; Yu H
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Progression of Poststroke Depression in Ischemic Stroke Patients Using the Patient Health Questionnaire-9.
    Fournier LE; Beauchamp JES; Zhang X; Bonojo E; Love M; Cooksey G; Hinojosa E; Okpala MN; Savitz SI; Sharrief AZ
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104561. PubMed ID: 31941579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs).
    Yi J; Lu J; Yang A; Marsh EB
    BMC Psychiatry; 2022 Nov; 22(1):722. PubMed ID: 36402974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it safe to use antidepressants after a stroke?
    Rampello L; Battaglia G; Raffaele R; Vecchio I; Alvano A
    Expert Opin Drug Saf; 2005 Sep; 4(5):885-97. PubMed ID: 16111451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-stroke depression (II): its differential diagnosis, complications and treatment].
    Carod-Artal FJ
    Rev Neurol; 2006 Feb 16-28; 42(4):238-44. PubMed ID: 16521063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine improves the quality of life in patients with poststroke emotional disturbances.
    Choi-Kwon S; Choi J; Kwon SU; Kang DW; Kim JS
    Cerebrovasc Dis; 2008; 26(3):266-71. PubMed ID: 18648199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of functional pharmacological therapy in post-stroke depression: a narrative review.
    Corallo F; Scarfì C; Arcadi FA; Formica C; Di Cara M; Palmeri R; Romeo L; Lo Buono V; Bramanti P; Marino S; De Cola MC
    J Int Med Res; 2020 Oct; 48(10):300060520950557. PubMed ID: 33081542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of milnacipran on poststroke depression on inpatient rehabilitation.
    Yamakawa Y; Satoh S; Sawa S; Ohta H; Asada T
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):705-10. PubMed ID: 16401247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.